Squarepoint
PHVS icon

Squarepoint’s Pharvaris PHVS Stock Holding History

Squarepoint’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54M Sell
44,629
-51,755
-54% -$1.57M ﹤0.01% 2539
2026
Q1 		$2.72M Sell
96,384
-3,975
-4% -$106K ﹤0.01% 1958
2025
Q4 		$2.78M Buy
+100,359
New +$2.42M ﹤0.01% 1842

Other funds holding PHVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Squarepoint's PHVS Position: Q2 2026 in Review

Squarepoint reduced its Pharvaris (PHVS) stake by 54% in Q2 2026, selling an estimated $1.57M and leaving 44,629 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #2539.

Squarepoint first reported a position in PHVS in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.78M in Q4 2025. 125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • Squarepoint held 44,629 shares of Pharvaris worth $1.54M as of Q2 2026.
  • Squarepoint sold 51,755 Pharvaris shares in Q2 2026, an estimated $1.57M.
  • Pharvaris made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2539 holding.
  • Squarepoint first reported a position in Pharvaris in Q4 2025 and has held it in 3 quarters since.
  • Squarepoint's Pharvaris position peaked at $2.78M in Q4 2025.
  • 125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.